Levonorgestrel/Ethinylestradiol Biogarancontinu

Ethinylestradiol / Levonorgestrel, the active ingredients in Levonorgestrel/Ethinylestradiol Biogarancontinu, are a combined oral contraceptive presented as a tablet for oral use. They prevent pregnancy in women of reproductive age.

GNH USA supplies Levonorgestrel/Ethinylestradiol Biogarancontinu as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levonorgestrel/Ethinylestradiol is a combined oral contraceptive that acts on the hormonal regulation of the menstrual cycle. - Contraception: prevents pregnancy by inhibiting ovulation and altering cervical mucus. - Menstrual cycle regulation: helps achieve more predictable bleeding patterns. - Dysmenorrhea management: reduces menstrual pain and associated cramps.

Levonorgestrel/Ethinylestradiol may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like. - Breast tenderness: temporary swelling or pain. - Spotting: irregular light bleeding between periods. - Weight change: slight increase or fluctuation. - Mood changes: irritability or mild depression.

Serious or Rare Side Effects: - Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism. - Hypertension: new‑onset or worsening high blood pressure. - Liver dysfunction: abnormal liver enzymes or jaundice. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Gallbladder disease: gallstones or cholecystitis. - Visual disturbances: sudden loss of vision or eye pain.

Before using Levonorgestrel/Ethinylestradiol, consider the following safety measures. - Smoking: avoid if over 35 years old, as risk of cardiovascular events rises. - Cardiovascular disease: assess risk of stroke, myocardial infarction, or clotting disorders. - Liver disease: use with caution in patients with hepatic impairment. - Migraine with aura: contraindicated due to increased stroke risk. - Pregnancy testing: confirm non‑pregnant status before initiation. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and light.

Levonorgestrel/Ethinylestradiol can interact with several medicines that affect hormone metabolism or clotting risk.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase bleeding risk. - Certain antiretrovirals (e.g., efavirenz, nevirapine): can reduce contraceptive efficacy. - Rifampicin and other enzyme inducers: lower hormone levels, risking contraceptive failure.

Moderate Interactions (Monitor Closely): - Antidepressants (e.g., sertraline): may increase risk of mood changes. - Anticonvulsants (e.g., carbamazepine, phenytoin): may modestly decrease hormone concentrations. - Herbal supplements (e.g., St John's wort): potential reduction in effectiveness.